About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 97 record(s)
Req # A-2022-155969
Briefing note CRA-2022-000355: CANADA REVENUE AGENCY 2022-2023 PUBLIC OPINION RESEARCH PLAN.Organization: Canada Revenue Agency
May 2023
Req # A-2022-158069
Complete copy of Briefing note ref. CRA-2022-000828, “Canada Dental Benefit (CDB) Delegation Authority Section 34,” Assessment and Benefit Services Branch.Organization: Canada Revenue Agency
May 2023
Req # A-2023-161469
A list, by name and dollar amount of all donations received by the MacDonald-Laurier Institute 855716585 RR 0001, from other Canadian charities, qualified donees and/or organizations in or outside of Canada between 2017 to 2022.Organization: Canada Revenue Agency
May 2023
Req # A-2023-161470
All disbursed funds by the MacDonald-Laurier Institute 855716585 RR 0001 for activities outside Canada by name of recipient, country of recipient, and dollar amount, from 2011 to 2022.Organization: Canada Revenue Agency
May 2023
Req # A-2022-001376
All correspondence between Health Canada Office of Pharmaceutical Management Strategies and the Patented Medicine Prices Review Board pertaining to the October 2022 revised draft Guidelines.Organization: Health Canada
May 2023
Req # A-2022-001415
Any internal or external communications from January 1, 2018 to December 31, 2022 involving the Minister of Health or a Health Canada employee at the level of Director General, Assistant Deputy Minister, Associate Deputy Minister, or Deputy Minister, regarding the regulatory guidance document(s) used for assessment of the COVID-19 "vaccines" Comirnaty and Spikevax; defining or re-defining the term "vaccine;" the definition of a “vaccine;” and the purpose of a vaccine.Organization: Health Canada
May 2023
Req # A-2022-001505
A list of all drug manufacturing plants currently banned from producing drugs for the Canadian market. Please include the reason for the ban, the location of the plant and the name of the company running the plant.Organization: Health Canada
May 2023
Req # A-2023-000080
Request to obtain licensing for the product “Reins” - Natural Product Number (NPN): 80003473.Organization: Health Canada
May 2023
Req # A-2020-001132
Adverse Drug Reactions (ADRs) for CABAZITAXEL. Report numbers: E2B_03023776, E2B_03023786.Organization: Health Canada
May 2023
Req # A-2020-001555
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-114221-353, Operational Readiness for Activities Related to COVID-19 Vaccines and Treatments.Organization: Health Canada
May 2023